Madhav Thambisetty, M.D.

Associated Investigator
E-mail: thambisettym@mail.nih.gov

Publications

Desai RJ, Varma VR, Gerhard T, Segal J, Mahesri M, Chin K, Horton DB, Kim SC, Schneeweiss S, Thambisetty M. Comparative risk of Alzheimer disease and related dementia among medicare beneficiaries with rheumatoid arthritis treated with targeted disease-modifying antirheumatic agents. JAMA Netw Open. 2022;5:e226567.
Varma VR, Büşra Lüleci H, Oommen AM, Varma S, Blackshear CT, Griswold ME, An Y, Roberts JA, O’Brien R, Pletnikova O, Troncoso JC, Bennett DA, Çakir T, Legido-Quigley C, Thambisetty M. Abnormal brain cholesterol homeostasis in Alzheimer’s disease – a targeted metabolic and transcriptomic study. NPJ Aging Mech Dis. 2021; 7:11.
Varma V, Oommen A, Varma S, Casanova R, An Y, Andrews R, O’Brien R, Pletnikova O, Troncoso J, Toledo J, Baillie R, Arnold M, Kastenmueller G, Nho K, Doraiswamy P, Saykin A, Kaddurah-Daouk R, Legido-Quigley C, Thambisett M. Brain and blood metabolite signatures of pathology and progression in Alzheimer’s disease: A targeted metabolomics study. PLoS Med 2018; 15: e1002482.
An Y, Varma V, Varma S, Casanova R, Dammer R, Pletnikova O, Chia C, Egan J, Ferrucci L, Troncoso J, Levey A, Lah J, Seyfried N, Legido-Quigley C, O’Brien R, Thambisetty M. Evidence for brain glucose dysregulation in Alzheimer’s disease. Alzheimers Dement 2018; 14: 318-329.

Director, Unit of Clinical & Translational Neuroscience, NIA